Search

Your search keyword '"Kaidashev I"' showing total 134 results

Search Constraints

Start Over You searched for: Author "Kaidashev I" Remove constraint Author: "Kaidashev I" Language english Remove constraint Language: english
134 results on '"Kaidashev I"'

Search Results

1. MMUNOLOGICAL FEATURES OF MACROPHAGES ASSOCIATED WITH METASTASIS OF PRIMARY BREAST CARCINOMA INTO REGIONAL LYMPH NODES

2. THE ROLE OF POLYMORPHISM OF THE COLLAGEN GENE 1 TYPE OF ALPHA-2 (COL1A2) (RS42524) IN THE DIAGNOSTIC METHODS OF THE EVALUATION OF POST-OPERATIVE SKIN SCARS LOCALIZED IN DIFFERENT AREAS OF THE HEAD AND NECK

3. QUANTITATIVE CHARACTERISTICS OF CD68+ AND CD163+ MACROPHAGES IN THE PRIMARY FOCUS AND IN METASTATIC LESIONS OF REGIONAL LYMPH NODES IN TRIPLE-NEGATIVE INVASIVE BREAST CARCINOMA

4. IL-26 in the induced sputum is associated with the level of systemic inflammation, lung functions and body weight in COPD patients

5. Erratum to: Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA

7. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

8. The ARIA-MeDALL hypothesis

9. Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA

10. Correlation between work impairment, scores of rhinitis severity and asthma using the MASK-air ® App

11. Is diet partly responsible for differences in COVID-19 death rates between and within countries?

12. Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis – A EUFOREA‐ARIA‐EPOS‐AIRWAYS ICP statement

13. Allergen immunotherapy in MASK-air users in real-life: Results of a Bayesian mixed-effects model

14. The Allergic Rhinitis and its Impact on Asthma (ARIA) Approach of Value-Added Medicines: As-Needed Treatment in Allergic Rhinitis

15. Behavioural patterns in allergic rhinitis medication in Europe: A study using MASK-air® real-world data

16. Assessment of the Control of Allergic Rhinitis and Asthma Test (CARAT) using MASK-air

17. ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle

18. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

19. Aligning the good practice mask with the objectives of the European innovation partnership on active and healthy ageing

20. MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation

22. Management of anaphylaxis due to COVID-19 vaccines in the elderly

26. ARIA pharmacy 2018 'Allergic rhinitis care pathways for community pharmacy'

27. Correction to: Is diet partly responsible for differences in COVID-19 death rates between and within countries? (Clinical and Translational Allergy, (2020), 10, 1, (16), 10.1186/s13601-020-00323-0)

28. Aligning the good practice mask with the objectives of the European innovation partnership on active and healthy ageing

29. Correction to: Is diet partly responsible for differences in COVID-19 death rates between and within countries? (Clinical and Translational Allergy, (2020), 10, 1, (16), 10.1186/s13601-020-00323-0)

30. PPAR-γ Agonist Pioglitazone Restored Mouse Liver mRNA Expression of Clock Genes and Inflammation-Related Genes Disrupted by Reversed Feeding.

31. Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis – A EUFOREA-ARIA-EPOS-AIRWAYS ICP statement

32. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

33. Adherence to treatment in allergic rhinitis using mobile technology. the mask study

34. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

35. 2019 ARIA Care pathways for allergen immunotherapy

36. ARIA pharmacy 2018 'Allergic rhinitis care pathways for community pharmacy': AIRWAYS ICPs initiative (European Innovation Partnership on Active and Healthy Ageing, DG CONNECT and DG Santé) POLLAR (Impact of Air POLLution on Asthma and Rhinitis) GARD Demonstration project

37. ARIA pharmacy 2018 'Allergic rhinitis care pathways for community pharmacy': AIRWAYS ICPs initiative (European Innovation Partnership on Active and Healthy Ageing, DG CONNECT and DG Santé) POLLAR (Impact of Air POLLution on Asthma and Rhinitis) GARD Demonstration project

38. Next-generation ARIA care pathways for rhinitis and asthma: A model for multimorbid chronic diseases

39. 2019 ARIA Care pathways for allergen immunotherapy

40. Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)(Clin Transl Allergy (2016) 6 (29) DOI: 10.1186/s13601-016-0116-9)

41. Однонуклеотидні поліморфізми TLR-2, TLR-3, TLR-4 та сприйнятливість до запальних захворювань дихальних шляхів

42. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

43. ARIA Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

44. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

45. Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)

47. Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5) (vol 6, 29, 2016)

48. PPAR-Gamma Agonist Pioglitazone Reduced CD68+ but Not CD163+ Macrophage Dermal Infiltration in Obese Psoriatic Patients.

49. MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis

50. OPTIMIZATION OF TREATMENT OF PATIENTS WITH INSULIN RESISTANCE TO REDUCE THE EXPRESSIVENESS OF CARDIOVASCULAR RISK FACTORS.

Catalog

Books, media, physical & digital resources